HAVCR2 and autoimmune thrombocytopenic purpura: Additionally, the messenger RNA levels of TIM-3 were found to be significantly decreased in PBMCs during the active stages of the ITP.48 In the present study, patients with ITP showed a significant decrease both in CD4+ frequency and CD4+ TIM-3 expression.